INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,817,426 | +19.7% | 1,339,304 | 0.0% | 2.50% | +14.4% |
| Q2 2023 | $28,259,314 | +23.8% | 1,339,304 | 0.0% | 2.18% | +44.9% |
| Q1 2023 | $22,835,133 | +36.1% | 1,339,304 | +59.4% | 1.51% | +43.8% |
| Q4 2022 | $16,783,200 | +1.2% | 840,000 | +9.1% | 1.05% | +32.5% |
| Q3 2022 | $16,586,000 | +9.2% | 770,000 | 0.0% | 0.79% | +5.7% |
| Q2 2022 | $15,184,000 | -8.5% | 770,000 | +9.1% | 0.75% | -14.5% |
| Q1 2022 | $16,587,000 | -12.5% | 705,838 | +1.4% | 0.88% | -2.6% |
| Q4 2021 | $18,955,000 | -1.1% | 695,840 | 0.0% | 0.90% | -9.4% |
| Q3 2021 | $19,163,000 | -3.2% | 695,840 | 0.0% | 0.99% | +12.9% |
| Q2 2021 | $19,804,000 | +27.3% | 695,840 | +52.4% | 0.88% | +36.8% |
| Q1 2021 | $15,553,000 | +8.6% | 456,631 | +6.2% | 0.64% | +4.6% |
| Q4 2020 | $14,318,000 | +3.6% | 430,107 | 0.0% | 0.61% | -10.5% |
| Q3 2020 | $13,824,000 | +16.7% | 430,107 | 0.0% | 0.69% | -10.3% |
| Q2 2020 | $11,845,000 | – | 430,107 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |